ReviewLeukemia2018

Front-line therapies for elderly patients with transplant-ineligible multiple myeloma and high-risk cytogenetics in the era of novel agents.

Herve Avet-Loiseau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.